Clinical Trials Directory

Trials / Completed

CompletedNCT00573183

Stimulant Abuser Groups to Engage in 12-Step

Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
471 (actual)
Sponsor
University of Washington · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes.

Detailed description

This protocol is to evaluate the degree to which a combined group and individual 12-Step facilitative (TSF) intervention, Stimulant Abuser Groups to Engage in 12 -Step (STAGE-12), improves substance -related outcomes compared to treatment as usual (TAU) without STAGE-12 among stimulant abusers. The primary objective is to evaluate reduction in percent of days of stimulant use as measured by self-report. Secondary objectives include evaluating reduction in percent days of use of other substances, the degree to which STAGE-12 increases involvement in 12-step activities and attendance at 12-step meetings, and the extent to which such 12 -step involvement and meeting attendance mediate substance use outcomes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSTAGE-12The STAGE-12 intervention will consist of a combination of five group and three individual sessions. The five group sessions will be taken from the Project MATCH Twelve Step Facilitation manual as modified for use with drug abusers and adapted for delivery in a group format. The group sessions will be augmented by three individual sessions derived from the introductory and termination sessions from the TSF manual and incorporating elements of the brief intensive 12-step referral procedure.
BEHAVIORALTreatment as Usual

Timeline

Start date
2008-01-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2007-12-14
Last updated
2016-12-05
Results posted
2014-01-29

Locations

10 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00573183. Inclusion in this directory is not an endorsement.